SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 362 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $942 | -94.8% | 14 | -89.4% | 0.00% | – |
| Q1 2023 | $18,194 | -99.6% | 132 | -99.5% | 0.00% | -100.0% |
| Q4 2020 | $4,993,000 | +76.2% | 29,288 | +45.2% | 0.10% | +53.2% |
| Q3 2020 | $2,833,000 | -23.9% | 20,174 | -13.1% | 0.06% | -29.5% |
| Q2 2020 | $3,723,000 | +57.0% | 23,222 | -4.2% | 0.09% | +29.4% |
| Q1 2020 | $2,371,000 | -4.1% | 24,235 | +26.5% | 0.07% | +21.4% |
| Q4 2019 | $2,472,000 | -38.4% | 19,157 | -27.5% | 0.06% | -41.7% |
| Q2 2019 | $4,014,000 | +55.0% | 26,415 | +21.6% | 0.10% | +54.8% |
| Q1 2019 | $2,589,000 | +783.6% | 21,721 | +708.7% | 0.06% | +675.0% |
| Q4 2018 | $293,000 | -86.8% | 2,686 | -80.4% | 0.01% | -85.7% |
| Q3 2018 | $2,217,000 | -6.5% | 13,731 | -67.8% | 0.06% | -13.8% |
| Q4 2017 | $2,372,000 | +49.6% | 42,631 | +21.9% | 0.06% | +41.3% |
| Q3 2017 | $1,586,000 | – | 34,972 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
| Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
| Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
| Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
| Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
| Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
| Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
| GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
| Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
| Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |